Logo Logo Logo Logo Logo
  • About
    • Board & Management
    • Business Development
  • Diagnostic Areas
    • COVID-19
    • Intelligent Innovation
  • Products & Solutions
    • Near-patient Workflow Solutions
  • News
  • Investors
    • Year in Review 2021
    • Corporate Calendar
    • Financial Reports
    • Leadership
    • General Meetings
    • Other Regulated Information
    • Advisor and Investor Contacts
    • AIM Rule 26 information
    • Corporate Governance
  • Our People
    • Careers
  • Contact
  • English
    • French
  • About
    • Board & Management
    • Business Development
  • Diagnostic Areas
    • COVID-19
    • Intelligent Innovation
  • Products & Solutions
    • Near-patient Workflow Solutions
  • News
  • Investors
    • Year in Review 2021
    • Corporate Calendar
    • Financial Reports
    • Leadership
    • General Meetings
    • Other Regulated Information
    • Advisor and Investor Contacts
    • AIM Rule 26 information
    • Corporate Governance
  • Our People
    • Careers
  • Contact
  • English
    • French
Search:

28 Jun Launch of monkeypox assay

Posted at 07:00h in Board, News, Novacyt Group, Products, Uncategorized

Paris, France and Camberley, UK – 28 June 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the launch of its research-use-only (RUO) polymerase...

Read More

21 Jun Notice of rescheduled AGM

Posted at 14:54h in Board, News, Novacyt Group, Products, Uncategorized

Paris, France and Camberley, UK – 21 June 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s Annual General Meeting (AGM),...

Read More

16 Jun DHSC dispute update

Posted at 06:00h in Board, News, Novacyt Group, Products, Uncategorized

Paris, France and Camberley, UK – 16 June 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its ongoing dispute with...

Read More

13 Jun AGM voting

Posted at 06:04h in Board, News, Novacyt Group, Products, Uncategorized

Paris, France and Camberley, UK – 13 June 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, will be holding its annual general meeting (AGM)...

Read More

01 Jun Publication of Annual Report and AGM voting

Posted at 06:00h in Events, News, Novacyt Group, Uncategorized

Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company's Annual Report and Accounts ("Annual Report") for the year ended 31 December 2021 has...

Read More

14 Jul Overwhelmed by COVID-19, are other serious infectious diseases neglected?

Posted at 09:56h in Blog, News, Videos, Webinar

The costs and healthcare challenges of tackling COVID-19 have threatened the world’s ability to address a steady rise in other serious infectious diseases. That’s the conclusion of a panel of experts...

Read More

24 Jun Don’t let COVID-19 distract you from a rise in other infectious diseases – stay alert!

Posted at 13:24h in Blog, COVID-19, News

The growth of the COVID-19 pandemic globally over the past 18 months has been exponential, and despite mitigating measures and the vaccine roll-out, the virus continues to mutate and spread. As...

Read More

01 Apr PathFlow®: Future innovation of COVID-19 Lateral Flow Testing

Posted at 14:07h in Blog, Blog, Blog, News

PathFlow®: Future innovation of COVID-19 Lateral Flow Testing Advancing technology and a unique wealth of knowledge are the driving forces behind innovative development in our PathFlow® portfolio of diagnostic tests...

Read More

27 Jan SARS-CoV-2 Mutations – Cause for Concern?

Posted at 13:08h in Blog, Blog, Blog, Blog, News

SARS-CoV-2 Mutations – Cause for Concern? The accumulation of genetic mutations is a normal part of viral evolution. Mutations change the sequence of the viral genome, creating different 'variants.' While some...

Read More

24 Dec What does the emergence of new SARS-CoV-2 variants mean for testing?

Posted at 14:52h in Blog, Blog, COVID-19, COVID-19, News

What does the emergence of new SARS-CoV-2 variants mean for testing? The UK has recently been at the centre of considerable media attention due to the detection of a large number...

Read More
  • 1
  • 2
  • 3

About


Novacyt is a leading global diagnostics company. We protect people and society in the fight against infectious diseases.

Company


Unit 1, Watchmoor Point, Watchmoor Road, Camberley, Surrey, GU15 3AD, UK

Novacyt UK Holdings - 12031776
Novacyt SA - 491062527

Latest reports


Investor Presentation April 2022
Year in Review 2021

© 2022 Novacyt | Privacy Policy | Copyright | Terms & Conditions

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT